Special Issues
Pharmaceuticals publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Melatonin Applications in Pharmaceutical Science
Deadline: 10 October 2026
Chronic Inflammation: Molecular Mechanisms and Precision Biomarkers
Deadline: 10 October 2026
Natural Pharmacons: Biologically Active Plant-Based Pharmaceuticals—4th Edition
Deadline: 15 October 2026
Allosteric Drug Design in the AI Era
Deadline: 15 October 2026
New Advances in Antiarrhythmic Drugs
Deadline: 20 October 2026
Advancements in Radiopharmaceutical Theranostics
Deadline: 20 October 2026
Next-Generation Targeted Therapy: vNARs, VHH, and Peptides as Drug Carriers and Intracellular Neutralizing Agents
Deadline: 20 October 2026
Natural Products in Gut Microbiome Modulation: Mechanisms and Clinical Applications
Deadline: 20 October 2026
Research on Diagnosis, Treatment and Related Microbiota in Gastrointestinal Diseases
Deadline: 25 October 2026
Epithelial Plasticity and Therapy Resistance in Cancer
Deadline: 25 October 2026
Pharmacovigilance Insights: Addressing Drug Misuse and Enhancing Drug Safety
Deadline: 25 October 2026
Synthesis, In Silico Prediction and Antitumor Activity of Nitrogen Heterocycle-Based Drug Development
Deadline: 25 October 2026
of 32

